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The body muscles of Caenorhabditis elegans extend
plasma membrane extensions called muscle arms to
the midline motor axons to form the postsynaptic
membrane of the neuromuscular junction. Through
a screen for muscle arm development defective
(Madd) mutants, we previously discovered that the
UNC-40/DCC guidance receptor directs muscle
arm extension through the Rho-GEF UNC-73. Here,
we describe a gene identified through our mutant
screen called madd-2, and show that it functions in
an UNC-40 pathway. MADD-2 is a C1-TRIM protein
and a homolog of human MID1, mutations in which
cause Opitz Syndrome. We demonstrate that
MADD-2 functions cell autonomously to direct
muscle and axon extensions to the ventral midline
of worms. Our results suggest that MADD-2 may
enhance UNC-40 pathway activity by facilitating an
interaction between UNC-40 and UNC-73. The analo-
gous phenotypes that result from MADD-2 and MID1
mutations suggest that C1-TRIM proteins may have
a conserved biological role in midline-oriented devel-
opmental events.
INTRODUCTION
Spatial cues along the dorsal-ventral circumferential axis are
essential in executing the body plan of many animals, including
our own. Cues typically accumulate to maxima or minima at
borders between the left and right sides of the developing
animal, called the dorsal and ventral midlines, respectively
(Hao et al., 2001; Kennedy et al., 1994; Kidd et al., 1999; Wads-
worth et al., 1996). Transmembrane receptors at the leading
edge of migrating cells, or at the leading edge of axonal growth
cones, translate positional information in the cell’s environment
into directed plasma membrane extension. Several components
that guide midline-oriented migrations were discovered using
the nematode Caenorhabditis elegans. For example, unc-5,
unc-6, and unc-40 mutants were isolated in the first C. elegans
forward genetic screen (Brenner, 1974), and were later recog-Develnized as mutations of key genes that guide circumferential cell
and growth cone migrations (Hedgecock et al., 1990). unc-6
encodes a secreted ligand with maximal expression near the
ventral midline (Wadsworth et al., 1996). UNC-5 is a transmem-
brane receptor of UNC-6/Netrin that acts in concert with UNC-
40/deleted in colorectal cancer (DCC), another transmembrane
protein, to guide migrating cells and axons away from UNC-6
(Chan et al., 1996; Hedgecock et al., 1990; Ishii et al., 1992).
Without UNC-5, UNC-40 guides migrations toward sources of
UNC-6 near the ventral midline (Chan et al., 1996; Hedgecock
et al., 1990).
Not only are many of the molecular details of the UNC-6
pathway conserved in more complex animals, but the pathway
regulates similar biological events. For example, the vertebrate
homolog of UNC-6, called Netrin, is enriched at the ventral floor
plate of the developing spinal cord (Serafini et al., 1994, 1996).
UNC-40 has two highly related mammalian Netrin-receptor
homologs, called neogenin (Keino-Masu et al., 1996; Vielmetter
et al., 1994) and DCC (Fearon et al., 1990). In a striking analogy to
the role of the worm homologs, DCC guides commissural spinal
axons toward the source of Netrin, whereas an UNC-5 homolog,
called RCM or UNC-5, guides trochlear motor axons away from
the source of Netrin (Ackerman et al., 1997; Keino-Masu et al.,
1996; Leonardo et al., 1997).
We recently showed that UNC-40 also guides muscle arm
extension to the midline of C. elegans (Alexander et al., 2009).
The body wall muscles (BWMs) of nematodes extend membrane
projections, called muscle arms, to the motor axons (Dixon and
Roy, 2005; White et al., 1986). Each muscle arm has an extended
stalk and an elaborate terminus that harbors the postsynaptic
machinery of neuromuscular junctions (White et al., 1986). The
95 mononucleated BWM cells of C. elegans are organized into
two dorsal and two ventral quadrants that flank the dorsal and
ventral midlines, respectively (Sulston and Horvitz, 1977). Each
quadrant is subdivided into a proximal row and a distal row
with respect to the nearest midline. The 79 dorsal and ventral
(body) BWMs extend muscle arms exclusively to the dorsal
and ventral nerve cords, respectively (Figure 1A).
Previous work demonstrated that muscle arms are likely
guided to the motor axons in a chemotropic fashion (Hall and
Hedgecock, 1991; Hedgecock et al., 1990), which inspired us
to use muscle arms as a model system with which to investigate
the genetics of guided migration (Dixon et al., 2006; Dixon and
Roy, 2005). In a forward genetic screen for muscle armopmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier Inc. 961
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Figure 1. The Muscle Arm Extension Defects of madd-2 Mutants
(A) A schematic of the dorsal BWM quadrants. Only the muscle arms of the
distal body muscles that express membrane-anchored YFP (Mb::YFP) from
the trIs30 transgenic array are highlighted (in red). The other muscles are indi-
cated in yellow, and the dorsal nerve cord is colored blue.
(B–E) The dorsal distal muscles in animals of the indicated genetic back-
ground. Each strain harbors the trIs30 array that expresses Mb::YFP in the
distal muscles (white) and DsRed in motor axons (blue). Dorsal right muscle
15 (Dr15) is indicated with a white arrow, and the muscle arms extended
from this muscle are indicated with red arrows. Anterior is oriented toward
the right. The scale bars represent 50 mm. (B) The wild-type control. (C) A
madd-2(tr103) null animal. (D and E) A madd-2(tr103) mutant rescued by
a transgenic array expressing a genomic version of madd-2 tagged with
GFP (D) (see Figure S1) and by muscle-specific expression of MADD-
2A::CFP from the pan-muscle promoter myo-3 (E).
(F and G) The average number of muscle arms per distal muscle of the dorsal
right quadrant. Df represents sDf75, a large chromosomal deletion that
uncovers madd-2. Standard error of the mean is shown. A black or red asterisk
indicates a significant difference (p < 0.001) relative to wild-type or madd-
2(tr103), respectively. The blue asterisk indicates a significant difference
(p < 0.001) relative to both madd-2(tr103)/+ and sDf75/+ heterozygotes. See
also Table S1.
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of unc-40, unc-73, and gex-2 (Alexander et al., 2009). We
demonstrated that UNC-40 is enriched at muscle arm termini,
and that it acts cell autonomously to direct muscle arm extension962 Developmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier Ithrough the conserved Rho guanine nucleotide exchange factor
(Rho-GEF) UNC-73B/Trio (Alexander et al., 2009). The Rho-GEF
domain of UNC-73B stimulates Racs (Steven et al., 1998), which
in turn stimulate Arp2/3-mediated actin-based membrane
extension via the WAVE complex (Miki et al., 1998). gex-2
encodes a homolog of the predicted WAVE-actin polymerization
complex member SraI/p140 (Soto et al., 2002).
Here, we present our characterization of madd-2, the largest
complementation group isolated from that screen. In addition
to extending fewer muscle arms to the midline, madd-2 mutants
have errors in both axon guidance and the extension of other
muscles to the ventral midline. We discovered thatmadd-2 func-
tions within the unc-40 pathway to regulate these midline-
oriented extensions. We show that MADD-2 binds the trans-
membrane receptor UNC-40 and the downstream Rho-GEF,
UNC-73. Our data suggests that MADD-2 may enhance the
activity of the UNC-40 pathway by facilitating the physical inter-
action between UNC-40 and UNC-73.
RESULTS
madd-2 Encodes a C1-TRIM Protein and Regulates
Muscle Arm Extension Cell Autonomously
As part of a forward genetic screen forC. elegans genes required
for muscle arm extension (Alexander et al., 2009), we isolated six
recessive alleles (tr64, tr96, tr101, tr103, tr113, and tr129) of
a single complementation group that we called madd-2. Most
body muscles of madd-2 mutants extend fewer than half the
wild-type number of muscle arms (Figure 1F; see Table S1 avail-
able online). Mapping of madd-2(tr64) placed it between 19.85
and 19.84 cM on chromosome V. Of the 32 genes within the
0.01 map unit region, we examined 5 candidates and found
mutations in the coding sequence of the C39F7.2 gene for 5 of
the 6 madd-2 alleles (Figure 2). The sixth allele, tr113, is a
complex rearrangement within C39F7.2 (Figure 2B). Six addi-
tional madd-2 alleles, tr150, tr162, tr163, tr171, tr187, and
tr189, were recovered in subsequent screens for additional
Madd mutants but were not characterized in detail (Figure 2;
Table S1). Also, an in-frame deletion allele of C39F7.2(ok2226)
was generated by the C. elegans knockout consortium (Fig-
ure 2B). We previously referred to our six original alleles of
C39F7.2 as madd-2 (Alexander et al., 2009). Hence, we and
the authors of a companion paper (Hao et al., 2010 [this issue
of Developmental Cell]) continue to refer to C39F7.2 as madd-2.
The madd-2 gene encodes the sole member of the C1
subfamily of tripartite motif (TRIM) proteins in the C. elegans
genome (Short and Cox, 2006). The C1 subfamily is defined by
an amino (N)-terminal ring finger (RING) domain, two B box
(BB) domains, a coiled-coil domain, a COS domain, a fibro-
nectin-type III (FNIII) domain, and a B30.2 domain (Figure 2)
(Short and Cox, 2006). Mammals have six genes encoding
C1-TRIM proteins (Short and Cox, 2006), yet there is no evidence
for a common biological or biochemical role of the members of
the C1 subfamily of TRIM proteins. The most extensively charac-
terized C1-TRIM is MID1/TRIM18, which regulates midline
development in humans (Quaderi et al., 1997). MID1 dimers
associate with microtubules, polyubiquitinate the catalytic
subunit of microtubule-associated protein phosphatase 2A
(PP2Ac), and target PP2Ac for degradation by the proteasomenc.
MADD-2 1 ---MEEELKCTICIRFFEDPIILTCGHSLCRMCALKAHQPSTS--------SGSSSTSSPRPS--------TPGILSQILSSASSP---ISPQSAGSSSG 78
Dm-TRIM9 1 ---MEDELRCPTCKQLYANPVLLPCFHALCLGCALDIQTPYSPGSALPGAVNGAGAASAAGHNGLHGNGGGAGGGAAAPVTNPNGPGTRHSSHSSAASTA 97
h-TRIM9 1 MEEMEEELKCPVCGSFYREPIILPCSHNLCQACARNILVQTPESE-------------------------------SPQSHRAAG-----------SGVS 58
h-TRIM67 1 ---MEEELKCPVCGSLFREPIILPCSHNVCLPCARTIAVQTPDGEQHLPQPLLLSRGSGLQAG--------AAAAASLEHDAAAGP------ACGGAGGS 83
h-MID1 1 METLESELTCPICLELFEDPLLLPCAHSLCFNCAHRILVSHCATN-----------------------------ESVESITAFQCP-------------- 57
h-MID2 1 METLESELTCPICLELFEDPLLLPCAHSLCFSCAHRILVSSCSSG-----------------------------ESIEPITAFQCP-------------- 57
MADD-2 79 ASDTMSLCVSDNGDHESDKLSVVSETDSG--------------VVGCGRTSRPSSIIGP-PLSRLHNILTPSTS-----GVQLVCNSCQKPSYFCDENSI 158
Dm-TRIM9 98 SSNTGSESVTSDQDQ-SDKVSIFSEADSG--------------VVCCSNTSRPVSYAGTGLLPGVGNVVAPPGA-----AYCLTCPLCRKLVFFDD-GGV 176
h-TRIM9 59 DYDYLD----------LDKMSLYSEADSGYGSYGGFASAPTTPCQKSPNGVRVFPPAMPPPATHLSPALAPVPR-----NSCITCPQCHRSLILDD-RGL 142
h-TRIM67 84 AAGGLGGGAGGGGDH-ADKLSLYSETDSGYGSY--------TPSLKSPNGVRVLPMVPAPPGSSAAAARGAACSSLSSSSSSITCPQCHRSASLDH-RGL 173
h-MID1 57 -----------------TCRHVITLSQRG--------------LDGLKRNVTLQNIIDRFQKASVSGPNSPSET-----------------------RRE 103
h-MID2 57 -----------------TCRYVISLNHRG--------------LDGLKRNVTLQNIIDRFQKASVSGPNSPSES-----------------------RRE 103
MADD-2 159 VSAPTNLAMQNVIRRYLLAHPDKAFLTPSCSGSSGSSGSSQSSDEASSQCQLCEGSENRMANVFCEQCDIYYCTPCQTALHPARGPLAKHNLLQA----- 253
Dm-TRIM9 177 RNLPTYRAMEAIVDRFCAR--------------------------EALRCQMCET-DPKVASLICEQCEIRYCDACRELTHPARGPLAKHTLVKP----- 244
h-TRIM9 143 RGFPKNRVLEGVIDRYQQSK------------------------AAALKCQLCEKAP-KEATVMCEQCDVFYCDPCRLRCHPPRGPLAKHRLVPP----- 212
h-TRIM67 174 RGFQRNRLLEAIVQRYQQGRG---------------AVPGTSAAAAVAICQLCDRTPPEPAATLCEQCDVLYCSACQLKCHPSRGPFAKHRLVQPPPPPP 258
h-MID1 104 RAFDANTMTS----------------------------------AEKVLCQFCDQDPAQDAVKTCVTCEVSYCDECLKATHPNKKPFTGHRLIEP----- 164
h-MID2 104 RTYRPTTAMS----------------------------------SERIACQFCEQDPPRDAVKTCITCEVSYCDRCLRATHPNKKPFTSHRLVEP----- 164
MADD-2 253 ---------NDGERKKSSAI-------------TTATTVRDLLRCATHPGEGLTMYCLACKVPVCSRCLQDLRHANHDVQSLPIACKGHKTELSTTLQQL 331
Dm-TRIM9 244 ---------RGAAQQRES-------------------------VCGEH-EETLSQYCLSCKAPACGLCIGELRHQAHDVQSINVTCKAQKTELSHNLQQL 309
h-TRIM9 212 ------------AQGRVSRR---LSP-------------RKVSTCTDHELENHSMYCVQCKMPVCYQCLEEGKHSSHEVKALGAMWKLHKSQLSQALNGL 284
h-TRIM67 259 PPAEAASGPTGTAQGAPSGGGGCKSPGGAGAGATGGSTARKFPTCPEHEMENYSMYCVSCRTPVCYLCLEEGRHAKHEVKPLGAMWKQHKAQLSQALNGV 358
h-MID1 164 ------------IPDSHIRG----------------------LMCLEHEDEKVNMYCVTDDQLICALCKLVGRHRDHQVAALSERYDKLKQNLESNLTNL 230
h-MID2 164 ------------VPDTHLRG----------------------ITCLDHENEKVNMYCVSDDQLICALCKLVGRHRDHQVASLNDRFEKLKQTLEMNLTNL 230
MADD-2 332 SEKAKTATEEIGRLKGLHDVVKNNCNDFKSSLCIQIDQLIEQLQMRKEKLMQHVDEQADNKRRILKSQIVKCTGKLTKTSALIQFCIEALKEPDPTVYMQ 431
Dm-TRIM9 310 SEKARSTTEFIQRLKGMSDKVTESCMEFERLVHAQCEALIQAIHDRREYLLEAIRMDKDTKIRILKDQQSNCTGKLQQTTGLIQFCIEALKETDSAAFLQ 409
h-TRIM9 285 SDRAKEAKEFLVQLRNMVQQIQENSVEFEACLVAQCDALIDALNRRKAQLLARVNKEHEHKLKVVRDQISHCTVKLRQTTGLMEYCLEVIKENDPSGFLQ 384
h-TRIM67 359 SDKAKEAKEFLVQLKNILQQIQENGLDYEACLVAQCDALVDALTRQKAKLLTKVTKEREHKLKMVWDQINHCTLKLRQSTGLMEYCLEVIKENDPSGFLQ 458
h-MID1 231 IKRNTELETLLAKLIQTCQHVEVNASRQEAKLTEECDLLIEIIQQRRQIIGTKIKEGKVMRLRKLAQQIANCKQCIERSASLISQAEHSLKENDHARFLQ 330
h-MID2 231 VKRNSELENQMAKLIQICQQVEVNTAMHEAKLMEECDELVEIIQQRKQMIAVKIKETKVMKLRKLAQQVANCRQCLERSTVLINQAEHILKENDQARFLQ 330
MADD-2 432 ISNALLHRSTSLEFLWHKEMR-TKPETDSEFVLNLDTKHLQYTIQTLDFAQLKAGPRGTRFKGDASRVPSAPIIETSECSAENNSVTVVWR-PRNDGSAV 529
Dm-TRIM9 410 VGSMLINRVTNTDMTWHQEVTNAAPRVSPIVDLTLDDAALARAIDNLNFIQMRA--------------PMTPTILPSDCSAENNSVTVAWQ-PPN-HSFV 493
h-TRIM9 385 ISDALIRRVHLTEDQWGKGTL--TPRMTTDFDLSLDNSPLLQSIHQLDFVQVKASSP----------VPATPILQLEECCTHNNSATLSWKQPPLSTVPA 472
h-TRIM67 459 ISDALIKRVQVSQEQWVKGAL--EPKVSAEFDLTLDSEPLLQAIHQLDFIQMKCR------------VPPVPLLQLEKCCTRNNSVTLAWRMPPFTHSPV 544
h-MID1 331 TAKNITERVSMATASSQVLIP-EINLNDTFDTFALDFSREKKLLECLDYLTAPNP----------------PTIREELCTASYDTITVHWTSDDEFSVVS 413
h-MID2 331 SAKNIAERVAMATASSQVLIP-DINFNDAFENFALDFSREKKLLEGLDYLTAPNP----------------PSIREELCTASHDTITVHWISDDEFSISS 413
MADD-2 530 DGFALEIDTGR--------DDGNFKEVYSGPDTICTIDGLHFNTVYAARVKSYNSAGESEYSESICLQTAHVAWFQLTKSPSQ---RDMILSNECATLSG 618
Dm-TRIM9 494 EGYVLELDDG---------SGGEFREVYCGKETICTVDGLHFNSMYNARVKAFNSAGEGEYSELIGLQTAEVAWFTFDPVLSGGAGSGLIFSKNNATVSV 584
h-TRIM9 473 DGYILELDDG---------NGGQFREVYVGKETMCTVDGLHFNSTYNARVKAFNKTGVSPYSKTLVLQTSEVAWFAFDPGSAH---SDIILSNDNLTVTC 560
h-TRIM67 545 DGYILELDDG---------AGGQFREVYVGKETLCTIDGLHFNSTYNARVKAFNSSGVGPYSKTVVLQTSDVAWFTFDPNSGH---RDIILSNDNQTATC 632
h-MID1 414 YELQYTIFTGQANVVSLCNSADSWMIVPNIKQNHYTVHGLQSGTKYIFMVKAINQAG-SRSSEPGKLKTNSQP-FKLDPKSAH---RKLKVSHDNLTVER 508
h-MID2 414 YELQYTIFTGQANFISLYNSVDSWMIVPNIKQNHYTVHGLQSGTRYIFIVKAINQAG-SRNSEPTRLKTNSQP-FKLDPKMTH---KKLKISNDGLQMEK 508
MADD-2 619 SSLEYR--------------TILGSIAFSKGVHYWEVTIDRHDGNSDIVIGVAQPAVNRNVMLGKDLHGWSMYVDGERSWYLHNETHHNRVLGGVTRGTV 704
Dm-TRIM9 585 EGWEHR--------------VALGSVGFSRGVHYWEFTIDNYTADTDPAFGVARIDVARNKMLGKDEKSFAMYIDRQRSWFQHNSIHERRVEGGITTGST 670
h-TRIM9 561 SSYDDR--------------VVLGKTGFSKGIHYWELTVDRYDNHPDPAFGVARMDVMKDVMLGKDDKAWAMYVDNNRSWFMHNNSHTNRTEGGITKGAT 646
h-TRIM67 633 SSYDDR--------------VVLGTAAFSKGVHYWELHVDRYDNHPDPAFGVARASVVKDMMLGKDDKAWAMYVDNNRSWFMHCNSHTNRTEGGVCKGAT 718
h-MID1 509 DESSSKKSHTPERFTSQGSYGVAGNVFIDSGRHYWEVVIS---GSTWYAIGLAYKSAPKHEWIGKNSASWALCRCNNNWVVRHNSKEIPIEPAPHLR--R 603
h-MID2 509 DESSLKKSHTPERFSGTGCYGAAGNIFIDSGCHYWEVVMG---SSTWYAIGIAYKSAPKNEWIGKNASSWVFSRCNSNFVVRHNNKEMLVDVPPHLK--R 603
MADD-2 705 IGVRLDCDRGTMEYTVNDRKRIYQDDSMAFTNMPRGLYYPAFSVNANSSITVHTGLSSPSS-------------------------- 765
Dm-TRIM9 671 IGVLLDLERHTLSFLVNEMP----QGSVAFRDLY-GVFYPAVSINRGVTLTMHTAMDAPKMDYF----------------------- 729
h-TRIM9 647 IGVLLDLNRKNLTFFINDEQ----QGPIAFDNVE-GLFFPAVSLNRNVQVTLHTGLPVPDFYSSRASIA------------------ 710
h-TRIM67 719 VGVLLDLNKHTLTFFINGQQ----QGPTAFSHVD-GVFMPALSLNRNVQVTLHTGLEVPTNLG-RPKLSGN---------------- 783
h-MID1 604 VGILLDYDNGSIAFYDALNS----IHLYTFDVAFAQPVCPTFTVWN-KCLTIITGLPIPDHLDCTEQLP------------------ 667
h-MID2 604 LGVLLDYDNNMLSFYDPANS----LHLHTFDVTFILPVCPTFTIWN-KSLMILSGLPAPDFIDYPERQECNCRPQESPYVSGMKTCH 685
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Figure 2. The Cloning of madd-2
(A) The physical and genetic interval of madd-2 was narrowed to between
19.85 cM and 19.84 cM on chromosome V using molecular mapping tech-
niques. Small ticks represent 10 kb. The arrows represent predicted genes.
The red arrows represent genes surveyed for polymorphisms in madd-2
mutants. One physical clone (fosmid WRM0617dB08) covered all of the
madd-2 locus (gene C39F7.2), except for the last exon (as indicated by the
vertical, dotted line in [B]).
(B) The genomic structure of themadd-2 gene. The alternatively spliced exon 8
is indicated with an asterisk. The 11 point mutations are indicated with black
arrows. The ok2226 deletion is indicated with a dashed, red line, and the region
encompassing the tr113 rearrangement is indicated with a dashed, blue line.
(C) A schematic of the predicted domain organization (to scale) of the 765
amino acid MADD-2 protein (based on PFAM predictions). The white insert
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Devel(Trockenbacher et al., 2001). Mutations in MID1 cause Opitz
Syndrome, which is characterized by numerous defects along
the ventral midline in humans (De Falco et al., 2003). It is unclear
why MID1 mutations result in ventral midline defects.
The characterization of 16 madd-2 cDNAs revealed that exon
8 was missing in 12 of the 16 cDNAs. Exon 8 encodes 14 resi-
dues that further separate the COS domain from the FNIII
domain and is not conserved with other C1-subfamily members
(Figure 2). We refer to the more prevalent isoform as MADD-2A,
and to the other form that includes exon 8 as MADD-2B. We
found that the muscle arm extension and axon guidance
defects of tr103 do not get worse when placed in trans to a defi-
ciency (Figures 1 and 5; Table S1). Together with the molecular
nature of the tr103 allele, our data indicate that tr103 is geneti-
cally null.
To test whether madd-2 functions cell autonomously, we ex-
pressed MADD-2 in either all BWMs (by using the myo-3
promoter) or only the distal BWMs (by using the him-4 promoter)
of tr103 mutants and observed complete rescue of the muscle
arm extension defects (Figure 1G). By contrast, neuronal expres-
sion of MADD-2 failed to rescue the muscle arm extension
defects of the madd-2 null mutant (Figure 1G). We conclude
that madd-2 functions cell autonomously to regulate muscle
arm extension.
MADD-2 Localizes to Muscle Arm Termini
To investigate the spatiotemporal expression pattern of madd-2,
we created two chromosomally integrated transgenic arrays
called trIs31 and trIs32 that express a MADD-2::GFP fusion
protein under the control of madd-2 promoter and enhancer
elements (Figure S1). trIs31 rescues the muscle arm extension
defects of madd-2 mutants (Figure 1G), demonstrating that the
MADD-2::GFP fusion protein is functional.
The expression pattern of MADD-2::GFP in animals carrying
trIs31 was characterized in detail and is similar to the pattern
observed in animals carrying trIs32. Weak MADD-2::GFP
expression was first observed in the ventral blast cells during
late gastrulation, followed by stronger expression in the over-
lying ventral hypodermal blast cells during enclosure (Figure 3).
MADD-2::GFP expression can also be seen in myoblasts at the
two-fold stage of development and persists in the BWMs
throughout the life of the animal. Within the BWMs, MADD-
2::GFP is localized to the dense bodies that anchor thin fila-
ments to the extracellular matrix (Lecroisey et al., 2007)
(Figure S2A). From the three-fold stage of embryonic develop-
ment, MADD-2::GFP is localized to the right side of the ventral
hypodermal ridge and to the left side of the dorsal hypodermal
ridge, where the ventral and dorsal major nerve cords,between the COS and FNIII domains represents the 14 residues encoded by
alternative exon 8. The domain acronyms are defined in the text. The point
mutations are indicated (nonsense mutations are represented by asterisks).
(D) A multiple sequence alignment of MADD-2, the Drosophila ortholog TRIM9
(AAP51207), and four of the six human paralogs (h MID1 (F269101), h MID2
(AF196481), h TRIM9 (AF220037)). Domains are indicated below the align-
ment, and mutations are indicated above (red square; nonsense mutation,
black square; missense mutation). The SPRY subdomain of B30.2 is indicated.
Note that the RING domain of the first four proteins is represented by the upper
red line, whereas the RING domain of MID1 and MID2 is represented by the
lower red line.
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Figure 3. TheExpressionPatternofMADD-2
(A–J0 ) All animals shown express functional MADD-
2::GFP driven by madd-2 regulatory elements from
the trIs31 transgene.
(A–D) Epifluorescent micrographs; (A0–D0 ) the cor-
responding light micrographs. The scale bar in (A)
represents 25 mm and is the same for (A)–(D0). (A
and B) Lateral and ventral views, respectively, of
a 350 min-stage embryo. MADD-2 is highly ex-
pressed in the ventral hypodermal blast cells
(arrow in [A]), which have extended to the ventral
midline (arrow in [B]). (C) As myogenesis ensues,
MADD-2 expression is visible in the myoblasts
(arrow).
(D) At the three-fold stage, asymmetric localization
of MADD-2 near the dorsal hypodermal ridge is
visible (arrow).
(E) A dorsal view of a second larval-stage (L2)
animal showing MADD-2 expression in the
BWMs and enrichment on the left side of the dorsal
hypodermal ridge. The scale bar represents 20 mm.
(F) A similar view as in (E), but of a young adult. For
(E) and (F), anterior is oriented toward the right. The
scale bar represents 50 mm.
(G) A merged image of MADD-2::CFP (green), ex-
pressed specifically in select BWMs with the
him-4 promoter, with a marker for the muscle
membrane (red). The arrowhead indicates
MADD-2 localization to the dense bodies.
(H–H00) Magnifications of the MADD-2::CFP locali-
zation at the muscle arm termini. The scale bars
in (G) and (H) represent 5 mm.
(I) A ventral-lateral view of a young adult. Enrich-
ment at the muscle arm termini is indicated with
a white arrowhead, and the SDQR and AVM
neurons are indicated. The vulva slit in (I)–(J0) is
indicated with a red arrowhead. The scale bar
represents 50 mm.
(J) MADD-2 is enriched at the site where the vulval
muscles contact the vulval epithelium.
(J0) A deeper focal plan of (J) showing the MADD-2
expression in the HSNr. The scale bar represents
25 mm. An extended description of the expression
pattern of MADD-2 is provided in Figures S2 and S3.
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MADD-2 Regulates Guidance to the Midlinerespectively, reside. Transgenic BWMs that are surrounded by
nontransgenic cells show nearby localization of MADD-2::GFP
at the hypodermal ridge, suggesting that MADD-2 is localized
postsynaptically and not within axons (Figure S2B). We also ex-
pressed CFP-tagged MADD-2 in select body muscles by using
the him-4 promoter (Dixon and Roy, 2005). The him-4 promoter
drives expression in the distal BWMs of each quadrant and not
within the nervous system. In these transgenic animals, MADD-
2::CFP is localized to the dense bodies and the muscle arm
termini in a pattern that recapitulates MADD-2::GFP localization
in strains carrying trIs31 (Figure 3; Figure S2C). We conclude
that MADD-2 is localized postsynaptically at the muscle arm
termini.
MADD-2::GFP is also expressed in the vulval muscles, the
anchor cell, the six ventral uterine precursor cells, the lateral
seam cells, and the ray precursor cells and their descendents in
males (Figure 3J; Figure S3). Other ectodermal derivatives that
express MADD-2::GFP include the hermaphrodite-specific
neurons (HSNs), and some Q cell descendents, including the964 Developmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier IAVM, PVM, SDQr, and SDQl neurons (Figures 3I and 3J, and
data not shown).
MADD-2 Likely Functions at the Leading Edge
to Regulate Muscle Arm Extension
To investigate MADD-2 domain function in vivo, we systemati-
cally deleted the domains of a MADD-2A::CFP fusion protein
and examined the function and localization of the resulting
mutant proteins in the muscles of living animals. The RING
domain of the MADD-2 homolog MID1 functions as an E3 ubiq-
uitin ligase (Trockenbacher et al., 2001). Disrupting MADD-2’s
RING domain through either deletion (MADD-2A(DR)) or the
substitution of a pair of cysteines that disrupt the E3 ligase
activity of RING domains (MADD-2A(C7S, C10S)) (Didier
et al., 2003) abrogated the fusion protein’s ability to rescue
the muscle arm extension defects of madd-2 null mutants
(Figure 4; Table S2). However, the subcellular localization
pattern of both of these mutant proteins was indistinguishable
from that of the full-length control, demonstrating that thenc.
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Figure 4. A Deletion Analysis of MADD-2
(A) The left side depicts the domain organization of
MADD-2 fusion proteins with the indicated alter-
ations. The domains are indicated at the top. The
table to the right summarizes the behavior of the
corresponding construct. The ability of the con-
struct to rescue the Madd phenotype of the
madd-2(tr103) null mutant is indicated. Here,
rescue indicates an average of 3 or more muscle
arms for dorsal right muscle 15 (DR15), as opposed
to the negative control, which has an average of 1.4
arms for DR15. A construct is considered to have
dominant-negative properties if it reduces arm
number below an average of 2.2 arms for DR15 in
an otherwise wild-type background, which nor-
mally extends an average of 3.6 muscle arms.
Three independently derived transgenic lines
were investigated for the enrichment of MADD-
2::CFP to arm termini and dense bodies. All three
lines behaved similarly for all constructs. Wild-
type and mutant MADD-2::CFP fusion proteins
were judged to be enriched at arm termini if obvi-
ously more signal and puncta were observed at
the termini compared to a uniform distribution of
the signal throughout the cytoplasm More details
are provided in Table S2.
(B) Examples of the behavior of the MADD-2::CFP-
related fusion proteins in DR15. The left column
shows the muscle plasma membrane marker and
whether the indicated transgene rescues the
muscle arm extension defects of the madd-2 null
mutant. The middle column again shows the
muscle plasma membrane marker (from trIs30)
and whether the indicated transgene induces
muscle arm extension defects in an otherwise
wild-type background. The muscle arms are indi-
cated with an arrowhead in both the left and middle
columns. The right column shows the localization
of either CFP (top panel) or MADD-2::CFP or the
indicated MADD-2::CFP mutant protein. Enrich-
ment of the MADD-2::CFP-related fusion proteins
at the arm termini is indicated with a black arrow,
and no enrichment is indicated with a white arrow.
MADD-2 proteins lacking the coiled-coil and addi-
tional C-terminal domains become nuclear local-
ized (black arrowhead). The relevant transgenic
protein is indicated in the upper left corner of
each micrograph. The asterisks in the lower right
panel indicate intestinal autofluorescence.
(C) A western blot showing MADD-2A::CFP and
selected MADD-2A::CFP mutant proteins. The
proteins were immunoprecipitated with polyclonal
anti-GFP antibodies and detected on the blot with
monoclonal anti-GFP antibodies (see Experimental
Procedures). A faint nonspecific band appears at
55 kDa (arrow). Large proteins (>80 kDa),
including MADD-2A::CFP, routinely run higher
than expected when using our methodology. The
predicted mass of the MADD-2 proteins is shown
above the blot, and the weights (kDa) of the ladder
proteins are shown on the left.
(D) A summary of domain function for MADD-2
(above the protein schematic) and MID1 (below
the protein schematic). Details of MID1 domain
function are described in the text. MT, microtu-
bules.
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MADD-2 Regulates Guidance to the MidlineRING domain is required for MADD-2 function, but is dispens-
able for its localization (Figure 4).
In an otherwise wild-type background, the expression of
MADD-2A(DR) or MADD-2A(C7S, C10S) induced muscle arm
extension defects (Figure 4) and did not enhance the Madd
phenotype of a madd-2(tr103) null mutant (Table S2). This domi-
nant-negative phenotype suggests that the mutant protein is
competing with wild-type MADD-2 for binding partners, but is
unable to execute its function and consequently debilitates the
MADD-2 protein complex. Hence, the MADD-2 domain(s) impor-
tant for protein-protein interactions might be inferred by deter-
mining which MADD-2 domain suppresss the dominant-nega-
tive phenotype when deleted in tandem with the RING domain.
Fusion proteins lacking the RING domain and BB2 and/or BB1
domains conferred the same dominant-negative phenotype as
MADD-2A(DR) (Figure 4). However, deleting the coiled-coil
domain in tandem with the RING and the two BB domains abol-
ished the dominant-negative effect (Figure 4). These results
suggest that the coiled-coil domain of MADD-2 mediates an
important protein-protein interaction.
The coiled-coil domain of human MID1 mediates homodime-
rization, which in turn is a prerequisite for its proper subcellular
localization (Short et al., 2002). We found that MADD-2’s
coiled-coil domain is required for MADD-2 localization to the
muscle arm termini. Fusion proteins lacking amino-terminal
domains up to the coiled-coil domain were properly localized
to the muscle arm termini (Figure 4). Upon deleting the
coiled-coil domain, however, localization to the termini was
abolished (Figure 4). A MADD-2 protein lacking only the
coiled-coil domain and the COS domain (into which the
coiled-coil domain is predicted to extend) also failed to localize
to the muscle arm termini. The coiled-coil and COS domains by
themselves could not mediate localization to the muscle arm
termini (Figure 4; Table S2). Consistent with the role of
MID1’s coiled-coil domain, our results suggest that MADD-2’s
coiled-coil domain is necessary, but not sufficient, for proper
subcellular localization.
To further investigate the role of MADD-2’s C-terminal
domains, we recreated the tr101(I530N) and tr64(L667F)
missense mutations in the FNIII and B30.2 domains of the
MADD-2::CFP fusion protein, respectively. As expected, neither
of these transgenic fusion proteins rescued the Madd pheno-
type of tr103 mutants (Figure 4). These two fusion proteins
also failed to localize to the muscle arm termini, but like all of
the MADD-2 fusion proteins, they were localized to the dense
bodies. The dense body localization, together with our western
analyses (Figure 4C), indicates that the mutant proteins were
not degraded. Given that the coiled-coil domain, the FNIII
domain, and the B30.2 domain were each required for both
MADD-2 function and MADD-2 localization to the muscle arm
termini, we conclude that MADD-2 likely functions at the leading
edge of extending muscle arms to regulate muscle arm
extension.
MADD-2 Functions in a UNC-40 Pathway to Direct Cell
Extensions to the Midline
Both MADD-2 and UNC-40 function cell autonomously to direct
muscle arm extension and localize to muscle arm termini
(Alexander et al., 2009). We therefore hypothesized that966 Developmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier IMADD-2 functions in the UNC-40 pathway. We tested this
hypothesis by using double-mutant analyses. A failure to
enhance the null mutant phenotype of one gene by a second
mutant gene that shares the same phenotype is strong evidence
that the two genes function in the same pathway; if two genes act
in independent pathways to regulate the same process, the
defects of the double mutant are expected to greatly exceed
those of the single null mutant. However, unc-40 extends very
few muscle arms (Alexander et al., 2009), leaving little room to
exhibit dramatic enhancement of the Madd phenotype. We
therefore investigated other MADD-2-expressing cells to deter-
mine whether madd-2 mutants might have additional pheno-
types that would be more amenable for genetic interaction anal-
yses. We discovered that MADD-2 is required in numerous cell
and axon extensions to the ventral midline that are described
below.
Four contralateral pairs of vulval muscles open the vulval slit
during egg laying (Sulston and Horvitz, 1977). Through mecha-
nisms that are not understood, the ventral side of each devel-
oping muscle extends to meet a contralateral homolog at the
ventral midline, while the other side attaches to body muscles
(Sulston and Horvitz, 1977) (Figure 5A). A total of 18% of the
anterior contralateral vulval muscle pairs in madd-2(tr103) null
mutants failed to meet at the midline, a phenotype we call vulval
muscle extension (Vme) defective (Figure 5D). The missense
madd-2 alleles, tr96 and tr101, have less penetrant defects
(Figure 5D). We also found that 84% of unc-40(n324) null animals
and less than 40% of unc-40(ev546) hypomorphic mutants have
the Vme phenotype. The madd-2(tr103) null mutation failed to
enhance the Vme phenotype of the unc-40(n324) null animals
(Figure 5D), suggesting that the two genes act in the same
pathway. Furthermore, the weak alleles of madd-2 dramatically
enhance the Vme phenotype of the unc-40(ev546) hypomorphs,
indicating that the relationship between the two genes is not
antagonistic.
We next examined the trajectory of the axons of the bilater-
ally symmetrical pair of HSNs because MADD-2 is expressed in
these cells. UNC-40 directs HSN axon extension ventrally in
response to the UNC-6/Netrin cue that is secreted near the
ventral midline (Adler et al., 2006; Chan et al., 1996; Hedgecock
et al., 1990). Consistent with previous observations, we
observed that 56% of the HSN axons on the right side (HSNr)
fail to extend to the ventral midline in unc-40 null mutants
and instead extend in other directions (Figure 5H). Upon exam-
ining the madd-2 null mutant, we found that 23% of the HSNr
axons fail to extend to the ventral midline. Expression of
MADD-2 in neurons, but not muscles, rescued the HSN axon
guidance defects (Figure 5H), consistent with a cell-autono-
mous role for MADD-2 in directing HSN axon guidance. We
found that the HSN axon guidance defects of both unc-40
null animals and madd-2 null mutants can be enhanced by
a mutation in slt-1, which encodes a component of a parallel
pathway. By contrast, unc-40 null mutants cannot be enhanced
by a null mutation of madd-2 (Figure 5H). Similar conclusions
were reached with the genetic analyses of the ventrally directed
AVM and PVM mechanosensory axons (Figures 5I–5L). We
conclude that madd-2 functions with unc-40 in parallel to the
slt-1 pathway to guide the HSN, AVM, and PVM axons to the
ventral midline.nc.
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Figure 5. madd-2 Functions in an unc-40 Pathway
(A–C) Vulval muscles as observed with the ayIs2[egl-15p::GFP] integrated
array (Harfe et al., 1998) in the indicated background. The ventral midline is
indicated with a white arrow. The scale bar represents 25 mm.
(D) Quantification of the vulval muscle extension (Vme) defects for the anterior
contralateral pair (Ant Vme) and the posterior contra-lateral pair (Post Vme).
(E–G) HSN axons are visualized with the mgIs42[tph-1p::GFP; rol-6(su1006)]
integrated array (Sze et al., 2000). The ventral midline is indicated with a red
arrowhead. The initial path of the HSNr axon is indicated with a yellow arrow.
The scale bars in (E)–(G) represent 25 mm.
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DevelMADD-2 Functions Upstream of UNC-40 and UNC-73
We investigated whether MADD-2 functions upstream or down-
stream of UNC-40 by using an approach similar to that used by
others to order gene products relative to UNC-40 in neurons (Gitai
et al., 2003; Levy-Strumpf and Culotti, 2007). We previously found
that overexpression of UNC-40 in the BWMs induces ectopic
myopodial extensions that can be suppressed by mutations in
the downstream Rho-GEF UNC-73 (Alexander et al., 2009).
Here, we asked whether madd-2(tr103) also suppresses UNC-
40::YFP-mediated myopodial extension, and we found no signifi-
cant difference between the number of myopodial extensions in
themadd-2(tr103)nullbackground (5.9± 0.5)and the control back-
ground (6.2 ± 0.4) (p > 0.05) (Figure S4). Furthermore, we found
that muscle-specific overexpression of either UNC-40::YFP or
UNC-73B::CFP suppresses the muscle arm extension defect of
madd-2(tr103) null mutants (p < 0.001) (Table S1). Together with
our results showing thatmadd-2 functions in the unc-40 pathway,
these results indicate that MADD-2 functions upstream of UNC-40
and UNC-73 to direct muscle membrane extension.
MADD-2 Physically Interacts with Both UNC-40
and UNC-73
MADD-2 and UNC-73 both function within the UNC-40 pathway
to direct muscle arm extension cell autonomously (this work;
Alexander et al., 2009). We therefore investigated the possibility
that MADD-2 physically interacts with UNC-40 and UNC-73.
First, we examined the subcellular localization of these tagged
proteins and found that MADD-2 colocalizes with UNC-40 and
UNC-73 at the muscle arm termini (Figures 6A and 6B). Despite
their colocalization, the abundance and localization of any one of
these three proteins is independent of the other two (Figures 6C–
6J). Using the yeast two-hybrid assay, we found that MADD-2
could physically interact with both UNC-40’s intracellular
domain (ICD) and UNC-73 (Figure 7A; Figure S5). Furthermore,
the addition of UNC-40(ICD) does not disrupt MADD-2’s interac-
tion with UNC-73, and the addition of UNC-73 does not disrupt
MADD-2’s interaction with UNC-40(ICD) in the yeast two-hybrid
assay (Figure 7A; Figure S5). Next, we expressed epitope-
tagged MADD-2 in the muscles of animals expressing either
GFP-tagged UNC-40 or UNC-73 in muscles. Immunoprecipitat-
ing MADD-2 coimmunoprecipitated UNC-40 and UNC-73 from(H) The percentage of HSN axons that fail to extend ventrally in the indicated
backgrounds. The deficiency (Df) used is sDf75. The ability of MADD-2A to
rescue the HSN axon guidance defects of the madd-2(tr103) null mutant
was tested by expressing MADD-2A in either the muscles (m), by using the
myo-3 promoter, or in neurons (n), by using the unc-119 promoter, from an
extrachromosomal array. Two independently derived lines were examined
for each array. Statistical comparisons for the rescued lines are made with
respect to the madd-2(tr103) null mutant.
(I–K) The mechanosensory axons are visualized with the muIs32 transgenic
array (Ch’ng et al., 2003). The AVM is indicated with a white arrowhead, the
ALMr is indicated with a blue arrowhead, and other axons at the ventral midline
are indicated with a red arrowhead. Anterior is oriented toward the right. The
scale bars in (I) and (J) represent 10 mm; the scale bar in (K) represents 5 mm.
(L) The percentage of AVM and PVM axons that fail to extend to the ventral
midline. The alleles used are the madd-2(tr103) null mutant, the unc-
40(n324) null mutant, and the slt-1(ok255) null mutant. Standard error of the
mean is shown in all bar graphs. Significant differences (p < 0.05) in phenotype
are indicated with asterisks. ns, no significant difference (p > 0.05). See also
Figure S4.
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Figure 6. MADD-2 Colocalizes with UNC-40 and
UNC-73, but Is Not Required for Their Localization
(A and B) MADD-2 is colocalized with UNC-40 and UNC-
73B at muscle arm termini (white arrowhead). (A) MADD-
2::CFP is expressed from the him-4 promoter from an
extrachromosomal transgenic (Ex) array, whereas UNC-
40::YFP is expressed from the him-4 promoter from the
trIs34 integrated transgenic array (Alexander et al., 2009).
(B) MADD-2::CFP is expressed from the him-4 promoter
from the trIs36 integrated array, whereas UNC-73B::YFP
is expressed from the him-4 promoter from an Ex array.
A single BWM is depicted in (A) and (B) (yellow arrowhead).
The scale bar represents 5 mm for both (A) and (B).
(C and D) Muscle-expressed UNC-40::YFP (from the trIs34
array) is localized to the muscle arm termini (white arrows)
in both a (C) wild-type and (D) madd-2(tr103) background.
(E and F) Muscle-expressed UNC-73B::CFP (from an Ex
array) is localized to the muscle arm termini (white arrows)
in both a (E) wild-type and (F) madd-2(tr103) background.
(G–I) MADD-2::GFP (driven by madd-2 enhancer elements
from the trIs31 integrated array) is localized to the muscle
arm termini (white arrows) in a (G) wild-type, (H) unc-
40(n324), and (I) unc-73(e936) background. For (C)–(I),
the red arrows indicate the vulval slit; the scale bar repre-
sents 50 mm.
(J) Quantification of the discontinuity of the midline locali-
zation of the indicated fusion protein in the indicated
genetic background. Ns, no significant difference (p >
0.05); na, not applicable because a t test comparison
between two zero values is not valid.
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MADD-2 Regulates Guidance to the Midlinethe respective worm strains (Figures 7B and 7C). Additional
controls show that MADD-2 and UNC-40 must be expressed in
the same animal to coimmunoprecipitate (Figure 7B). Muscle-
expressed epitope-tagged UNC-40 was also able to coimmuno-
precipitate UNC-73 (Figure 7D).
Previous work demonstrated that UNC-40 physically inter-
acts with UNC-73 in a yeast two-hybrid assay that employs 2
micron (m)-based vectors (Watari-Goshima et al., 2007). We
found that we could recapitulate this interaction by using the
2 m-based vectors; however, when we used centromeric-based
vectors, UNC-40 and UNC-73 did not interact (Figure 7A;
Figure S5). Fewer copies of centromeric-based yeast vectors
are maintained per cell compared to 2 m-based vectors and
are therefore expected to drive lower levels of protein expres-
sion. We tested the idea that MADD-2 might facilitate the inter-968 Developmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier Inc.action between UNC-40 and UNC-73 by intro-
ducing nuclear-localized MADD-2 without
fusing it to any GAL4 domains in a centro-
meric-vector-based three-hybrid assay. We
found that MADD-2 facilitated the physical
interaction between UNC-40 and UNC-73
(Figure 7A; Figure S5). We also have preliminary
evidence that coimmunoprecipitation of
muscle-expressed UNC-40::YFP and native
UNC-73 is reduced in madd-2 null mutant
animals (data not shown), but reagent avail-
ability has hampered our ability to verify these
results in a definitive manner. We conclude
that MADD-2 may potentiate the physical inter-action between the UNC-40 receptor and the downstream
Rho-GEF UNC-73.
DISCUSSION
Here, we describe MADD-2, which acts in concert with the
UNC-40 transmembrane receptor and the UNC-73 Rho-GEF to
guide muscle and axonal extensions to the midline. Several lines
of evidence indicate that MADD-2 may act to enhance UNC-40-
mediated signal transduction through UNC-73. First, MADD-2
colocalizes with both UNC-40 and UNC-73 at muscle arm
termini. Second, epitope-tagged MADD-2 coimmunoprecipi-
tates with epitope-tagged UNC-40 and UNC-73 when ex-
pressed in muscle cells. Third, yeast two- and three-hybrid anal-
yses suggest that, at high concentrations, UNC-40 interacts with
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Figure 7. MADD-2, UNC-73, and UNC-40 Physically Interact
(A) A summary of the yeast two- and three-hybrid analyses. ‘‘X’’ indicates no
interaction, a check mark indicates an interaction, and a blank indicates that
the experiment was not attempted. The analyses are shown in full detail in
Figure S5.
(B–E) Coimmunoprecipitation of transgenic proteins expressed from the
muscles of whole worms. All fusion proteins were expressed from the him-4
promoter and from integrated functional transgenes, except for UNC-
73B::3XFLAG::YFP (D), which was expressed from the myo-3 promoter and
a functional extrachromosomal array. For (B)–(E), the blot on the right shows
the proteins immunoprecipitated with polyclonal anti-GFP antibodies, and
the blot on the left shows the proteins immunoprecipitated with monoclonal
M2 anti-FLAG antibodies. All blots were probed with anti-GFP antibodies
(see Experimental Procedures for details), which bind both CFP and YFP. The
approximate molecular weight (kDa) of the ladder proteins are indicated to
the right of the blots. (B) MADD-2::FLAG::CFP coimmunoprecipitates UNC-
40::YFP. Their coimmunoprecipitation is dependent on the two proteins being
expressed in the same animal, because when one strain expressing only
MADD-2::FLAG::CFP is mixed with another strain expressing only UNC-
40::YFP, and then lysed (outlined ‘‘+’’ marks), MADD-2::FLAG::CFP cannot
coimmunoprecipitate UNC-40::YFP. Minor lower-molecular weight isoforms
of both UNC-40 and MADD-2 are present. (C) MADD-2::FLAG::CFP can
coimmunoprecipitate MYC::UNC-73B::YFP.
(D) UNC-73B::3XFLAG::YFP can coimmunoprecipitate UNC-40::YFP. Note that
the UNC-73B fusion protein also has a MYC epitope between UNC-73B and
the FLAG tags. Also note that in the anti-GFP immunoprecipitation, the
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DevelUNC-73, but that, at lower concentrations, MADD-2 is necessary
for the UNC-40-UNC-73 interaction. Fourth, overexpression of
either UNC-40 or UNC-73 suppresses the muscle arm extension
defects of a madd-2 null mutant, indicating that MADD-2 is not
required if the concentration of UNC-40 or UNC-73 is artificially
increased in the cell. Finally, the muscle arm extension and axon
guidance defects of the madd-2 null mutant are less severe than
those of the unc-40 null mutant (unc-73 null mutants are subvi-
able), suggesting that MADD-2 enhances the otherwise nominal
activity of the UNC-40 pathway. Together, our observations
suggest that MADD-2 may enhance signal transduction through
the UNC-40 pathway by facilitating a physical interaction
between UNC-40 and UNC-73.
We have previously demonstrated that UNC-73 functions
downstream of UNC-40 to direct muscle arm extension (Alex-
ander et al., 2009). Others have demonstrated that UNC-73 func-
tions upstream of UNC-40 to direct ALM axon extension along
the anterior-posterior axis (Levy-Strumpf and Culotti, 2007; Wa-
tari-Goshima et al., 2007). A major distinction between these two
observations is that UNC-5 facilitates ALM axonal extension
(Levy-Strumpf and Culotti, 2007; Watari-Goshima et al., 2007),
but not muscle arm extension (Alexander et al., 2009). Hence,
the nature of the relationship between UNC-40 and UNC-73
may be dependent on the presence of UNC-5. We can infer
that different proteins must facilitate UNC-40 signal transduction
through UNC-73 compared to UNC-40 signal transduction
through other cytoskeletal modulators. Indeed, MADD-2
appears to be one of these proteins that facilitates only the
UNC-5-independent mode of UNC-40 function. For example,
the guidance of commissural axons and the distal tip cells,
each of which require UNC-40 and UNC-5 (Hedgecock et al.,
1990), does not require MADD-2 (nor can we detect MADD-2
expression in either of these cell types). By contrast, muscle
arm extension and HSN, AVM, and PVM axon guidance are facil-
itated by MADD-2, but not UNC-5 (Alexander et al., 2009;
Hedgecock et al., 1990). Thus, MADD-2 may facilitate UNC-40
signal transduction through UNC-73 in UNC-5-independent
guidance events, but may be unnecessary if UNC-40 signals
through other cytoskeletal modulators in UNC-5-dependent
guidance events.
The RING domain of the MADD-2 homolog MID1 is an E3 ubiq-
uitin ligase that polyubiquitinates PP2Ac and targets it for pro-
teosomal degradation (Trockenbacher et al., 2001). It is currently
unclear whether MADD-2 has enzymatic activity and, if so,
whether it has any bearing on the UNC-40 pathway. We have
demonstrated that MADD-2’s RING domain is required for
muscle arm extension, and that a pair of mutations that is
commonly used to disrupt the ubiquitin ligase activity of RING
domains (C7S, C10S) also disrupts MADD-2 function without
altering its localization or abundance. However, the abundance
of muscle-expressed CFP-tagged PP2Ac is not altered upon
eliminating or increasing MADD-2 abundance (M.A. and P.J.R.,UNC-40::YFP (left lane) and the Mb::YFP that is present in the UNC-73B::
3XFLAG::YFP-only lane (middle lane) out-competes UNC-73B::3XFLAG::YFP,
which is less abundant because it is expressed from an extrachromosomal
array. (E) MADD-2::FLAG::CFP fails to coimmunoprecipitate the abundantly
expressed membrane-anchored (Mb) YFP, indicating that interactions between
GFP-derived proteins are insufficient to mediate coimmunoprecipitation.
opmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier Inc. 969
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targets PP2Ac for degradation through polyubiquitination.
Furthermore, the subcellular localization and abundance of
UNC-40 and UNC-73 do not change in the absence of
MADD-2, indicating that it is also unlikely that MADD-2 ubiquiti-
nates its known binding partners. Further investigation is required
to determine the function of the RING domain of MADD-2.
Despite the apparent difference in the function of the RING
domain, there are numerous similarities between MADD-2 and
MID1. For example, the coiled-coil domain, the FNIII domain,
and the B30.2 domain of MADD-2 and MID1 are all required
for proper subcellular localization in both worms and human
cells, respectively (Short et al., 2002). In addition, MADD-2 and
MID1 subcellular localization are both dependent on microtu-
bules (M.A. and P.J.R., unpublished data) (Short et al., 2002).
However, the most striking similarity between MADD-2 and
MID1 is their loss-of-function phenotypes. In humans with
MID1 mutations, numerous tissues along the ventral midline
develop incorrectly. Although the nature of the cellular defects
that result in ventral midline defects is not known, much of the
defective tissue is derived from neural crest cells that undergo
an extensive circumferential migration from the dorsal midline
(Schweiger and Schneider, 2003). In worms, numerous cells
along the length of the animal require MADD-2 to extend
membrane circumferentially to the ventral midline, including
BWMs, vulva muscles, the male sex muscles, and the HSN
neurons. Many of the molecular mechanisms that guide the
migration of vertebrate neural crest cells or their derivatives are
similar to those that guide circumferential extensions and migra-
tions in C. elegans (Jiang et al., 2003; Kee et al., 2007). We there-
fore speculate that MID1 may act like MADD-2 to regulate an
UNC-40-like pathway in mammals. Decreased activity of an
UNC-40-like pathway in tissues that normally express MID1
may be at the root of Opitz Syndrome pathology.EXPERIMENTAL PROCEDURES
Strains, Mapping, and Phenotypic Analyses
All worm strains were grown at 20C by using standard techniques (Brenner,
1974) unless otherwise indicated. The following strains were obtained from
the CGC: BC3958 (dpy-18(e364)/eT1 III; sDf75 unc-46(e177)/eT1[let-
500(s2165)]V); CF1665 (muIs32 II); qid-7(mu327) X, GR1366 (mgIs42),
NH2447 (ayIs2 IV); RB1741 (C39F7.2(ok2226) V). unc-40(ev546) was a kind
gift from Joe Culotti. We found that ev546 carries a G774R missense mutation
in the fourth fibronectin type III domain of UNC-40.
The tr64 mutation was mapped to a 228 kb region on the left arm of chromo-
some V using snip-SNP mapping (Wicks et al., 2001). Candidate genes in
the region were examined for polymorphisms by using a SURVEYOR kit (Trans-
genomic, Inc). Upon detecting polymorphisms in the C39F7.2 gene in madd-2
mutant backgrounds, we sequenced all madd-2 alleles to find the mutated
base pairs. Analysis of madd-2 alleles in trans to a deficiency was done by
crossing madd-2(tr103)/+; trIs30/+ and madd-2(tr64)/+; trIs30/+ males into
sDF75 hermaphrodites and counting muscle arms of fluorescent F1 progeny.
Muscle arm counts were done as previously described (Dixon and Roy,
2005). The mean and standard error of the mean for Vme, AVM, PVM, and
HSN defects were determined by counting defects of 50 animals from 3 inde-
pendent replicates. A Student’s t test analysis was used to determine signifi-
cance for all counts.
Transgenics
Muscle-specific rescue of madd-2(tr103) was done by injecting 100 ng/ml
pPRGS263 (myo-3p::MADD-2A minigene) construct, which directs the970 Developmental Cell 18, 961–972, June 15, 2010 ª2010 Elsevier Iexpression of MADD-2A cDNA (yk78e9 from Y. Kohara), or 100 ng/ml
pPRGS274 (him-4p::MADD-2A::CFP) or pPRGS272 (him-4p::MADD-
2B(yk246e12 cDNA)::CFP). pPD133.45 (myo-3p::NLS::CFP::LacZ), a gift
from Andrew Fire, was used as a coinjection marker. MADD-2A was expressed
neuronally by injecting 100 ng/ml pPRGS407(unc-119p::MADD-2A::CFP)
along with 20 ng/ml of the coinjection marker pPRGS382 (myo-2p::mCherry).
Muscle-specific deletion and mutant MADD-2A::CFP constructs, which were
derived from pPRGS274, were injected with the coinjection marker pRF4
(rol-6(su1006)) at 100 ng/ml each into wild-type (N2) and trIs30; madd-
2(tr103) worms to assay localization and functionality, respectively. The
pRFGS316 (him-4p::CFP) construct was injected at 2 ng/ml to obtain CFP
expression levels that were comparable to the other constructs. For each
construct, rescue and localization were analyzed in three independently
derived lines. The localization of the fusion protein to muscle arm termini
and dense bodies as well as the expression level were qualitatively deter-
mined. All constructs were verified by sequencing the resulting manipulated
DNA. Maps, notes, and sequences are available upon request.
Yeast Two- and Three-Hybrid Analyses
Full details of the yeast two- and three-hybrid analyses are given in Figure S5.
The full-length MADD-2A and UNC-73B open reading frames and the cyto-
plasmic region of UNC-40 (residues K1108–K1415) were used in the assays.
Immunoprecipitation
A total of 350 ml of mixed-stage packed worms were washed thrice with M9
solution and once with PBS, and were then resuspended in 700 ml ice-cold
Solubilization buffer (25 mM Tris [pH 7.4], 100 mM NaCl, 1 mM EDTA,
0.25% NP40, 1 mM PMSF, 1 mM Na3VO4, 2.5 mg/ml Pepstatin-A, 10 mM
NaF, and 1 protease inhibitor cocktail tablet [Roche] per 10 ml solution). The
samples were incubated on ice for 30 min, then subjected to three cycles of
flash freezing in liquid nitrogen, partial thawing, and sonnication for 5 s at
7 Watts. Next, the samples were incubated at 4C with agitation for 30 min
and then centrifuged (13,000 rpm, 30 min, 4C). A BCA assay (Thermo Scien-
tific) was used to measure the protein concentration in the supernatant. A total
of 4 mg/ml protein lysate was incubated with either 20 ml packed Antiflag M2
agarose-coupled antibody (Sigma) or 20 ml packed Protein A/G agarose beads
(SantaCruz Biotechnology) along with 2 mg polyclonal GFP antibody (Gen-
Script) for 3 hr with agitation at 4C. The agarose beads were centrifuged
and washed five times with 1 ml cold Solubilization buffer. A total of 100 ml
23 Laemmli sample buffer was then added to the beads, and the samples
were boiled and analyzed by western blot. The FLAG-immunoprecipitated
samples were analyzed by using an anti-GFP polyclonal antibody and an
anti-rabbit HRP-conjugated secondary antibody (SantaCruz Biotechnology).
The GFP-immunoprecipitated samples were analyzed by using an anti-GFP
monoclonal antibody and an anti-mouse HRP-conjugated secondary antibody
(SantaCruz Biotechnology). The integrated transgenes used in the coimmuno-
precipitation experiments are as follows: trIs44 [him-4p::MADD-2A::FLAG::
CFP; rol-6(su1006)], trIs41 [him-4p::UNC-40::YFP; rol-6(su1006)], trIs46
[him-4p::MYC::UNC-73B::YFP; rol-6(su1006)], trIs30 [him-4p::Mb::YFP; hmr-
1bp::DsRed2; unc-129snp::DsRed2].
SUPPLEMENTAL INFORMATION
Supplemental Data include five figures and two tables and can be found with
this article online at doi:10.1016/j.devcel.2010.05.016.
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